117 related articles for article (PubMed ID: 20452674)
1. Dimethyl titanocene Y: a valuable precursor for libraries of cytotoxic titanocene derivatives.
Immel TA; Martin JT; Dürr CJ; Groth U; Huhn T
J Inorg Biochem; 2010 Aug; 104(8):863-7. PubMed ID: 20452674
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
[TBL] [Abstract][Full Text] [Related]
3. Pseudo-halide derivatives of titanocene: synthesis and cytotoxicity studies.
Claffey J; Deally A; Gleeson B; Hogan M; Méndez LM; Müller-Bunz H; Patil S; Wallis D; Tacke M
Metallomics; 2009 Nov; 1(6):511-7. PubMed ID: 21305159
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
5. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
6. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters.
Erxleben A; Claffey J; Tacke M
J Inorg Biochem; 2010 Apr; 104(4):390-6. PubMed ID: 20036426
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.
Chimento A; Saturnino C; Iacopetta D; Mazzotta R; Caruso A; Plutino MR; Mariconda A; Ramunno A; Sinicropi MS; Pezzi V; Longo P
Bioorg Med Chem; 2015 Nov; 23(22):7302-12. PubMed ID: 26526741
[TBL] [Abstract][Full Text] [Related]
10. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.
Weber H; Claffey J; Hogan M; Pampillón C; Tacke M
Toxicol In Vitro; 2008 Mar; 22(2):531-4. PubMed ID: 17981007
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content.
Kaluderović GN; Pérez-Quintanilla D; Zizak Z; Juranić ZD; Gómez-Ruiz S
Dalton Trans; 2010 Mar; 39(10):2597-608. PubMed ID: 20179853
[TBL] [Abstract][Full Text] [Related]
12. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.
Ravera M; Cassino C; Monti E; Gariboldi M; Osella D
J Inorg Biochem; 2005 Dec; 99(12):2264-9. PubMed ID: 16209887
[TBL] [Abstract][Full Text] [Related]
14. Titanocene difluorides with improved cytotoxic activity.
Eger S; Immel TA; Claffey J; Müller-Bunz H; Tacke M; Groth U; Huhn T
Inorg Chem; 2010 Feb; 49(4):1292-4. PubMed ID: 20055428
[TBL] [Abstract][Full Text] [Related]
15. In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
Kelter G; Sweeney NJ; Strohfeldt K; Fiebig HH; Tacke M
Anticancer Drugs; 2005 Nov; 16(10):1091-8. PubMed ID: 16222151
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of anticancer titanocene derivatives: an insight from quantum chemical calculations.
Sponer JE; Leszczynski J; Sponer J
J Phys Chem B; 2006 Oct; 110(39):19632-6. PubMed ID: 17004831
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
Fichtner I; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2006 Mar; 17(3):333-6. PubMed ID: 16520662
[TBL] [Abstract][Full Text] [Related]
18. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agents.
Pampillón C; Claffey J; Strohfeldt K; Tacke M
Eur J Med Chem; 2008 Jan; 43(1):122-8. PubMed ID: 17412456
[TBL] [Abstract][Full Text] [Related]
20. New Titanocene (IV) Dicarboxylates with Potential Cytotoxicity: Synthesis, Structure, Stability and Electrochemistry.
Guk DA; Gibadullina KR; Burlutskiy RO; Pavlov KG; Moiseeva AA; Tafeenko VA; Lyssenko KA; Gandalipov ER; Shtil AA; Beloglazkina EK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
